Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Dominguez, I; Pastor, N; Mateos, S; Cortes, F
   Testing the SCE mechanism with non-poisoning topoisomerase II inhibitors
   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
   
   I. Dominguez et al., "Testing the SCE mechanism with non-poisoning topoisomerase II inhibitors", MUT RES-GTE, 497(1-2), 2001, pp. 71-79
2. Chavalitshewinkoon-Petmitr, P; Pongvilairat, G; Ralph, RK; Denny, WA; Wilairat, P
   Inhibitory effects of 9-anilinoacridines on Plasmodium falciparum gametocytes
   TROPICAL MEDICINE & INTERNATIONAL HEALTH
   
   P. Chavalitshewinkoon-Petmitr et al., "Inhibitory effects of 9-anilinoacridines on Plasmodium falciparum gametocytes", TR MED I H, 6(1), 2001, pp. 42-45
3. Hooper, DC
   Emerging mechanisms of fluoroquinolone resistance
   EMERGING INFECTIOUS DISEASES
   
   D.C. Hooper, "Emerging mechanisms of fluoroquinolone resistance", EM INFECT D, 7(2), 2001, pp. 337-341
4. Lin, DM; Chen, TY; Wang, LF; Hui, CF; Hwang, J
   Characterization of drug resistance to VM-26 in A2780 ovarian carcinoma cells
   ZOOLOGICAL STUDIES
   
   D.M. Lin et al., "Characterization of drug resistance to VM-26 in A2780 ovarian carcinoma cells", ZOOL STUD, 40(1), 2001, pp. 71-78
5. Okamoto, R; Takano, H; Sekikawa, T; Tanaka, T; Toyada, M; Ukon, K; Tanimoto, K; Kumazaki, T; Nishiyama, M
   Unique action determinants of double acting topoisomerase inhibitor, TAS-103
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   R. Okamoto et al., "Unique action determinants of double acting topoisomerase inhibitor, TAS-103", INT J ONCOL, 19(5), 2001, pp. 921-927
6. Mekapati, SB; Hansch, C
   Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase I
   BIOORGANIC & MEDICINAL CHEMISTRY
   
   S.B. Mekapati e C. Hansch, "Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase I", BIO MED CH, 9(11), 2001, pp. 2885-2893
7. Zhao, LX; Kim, TS; Ahn, SH; Kim, TH; Kim, EK; Cho, WJ; Choi, H; Lee, CS; Kim, JA; Jeong, TC; Chang, CJ; Lee, ES
   Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2 ':6 ',2 ''-, 2,2 ': 6 ',3 ''- and 2,2 : 6 ',4 ''-terpyridine derivatives
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   L.X. Zhao et al., "Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2 ':6 ',2 ''-, 2,2 ': 6 ',3 ''- and 2,2 : 6 ',4 ''-terpyridine derivatives", BIOORG MED, 11(19), 2001, pp. 2659-2662
8. Stewart, AJ; Mistry, P; Dangerfield, W; Bootle, D; Baker, M; Kofler, B; Okiji, S; Baguley, BC; Denny, WA; Charlton, PA
   Antitumor activity of XR5944, a novel and potent topoisomerase poison
   ANTI-CANCER DRUGS
   
   A.J. Stewart et al., "Antitumor activity of XR5944, a novel and potent topoisomerase poison", ANTI-CANC D, 12(4), 2001, pp. 359-367
9. Matsumoto, Y; Takano, H; Nagao, S; Fojo, T
   Altered topoisomerase II alpha and multidrug resistance-associated proteinlevels during drug selection: Adaptations to increasing drug pressure
   JAPANESE JOURNAL OF CANCER RESEARCH
   
   Y. Matsumoto et al., "Altered topoisomerase II alpha and multidrug resistance-associated proteinlevels during drug selection: Adaptations to increasing drug pressure", JPN J CANC, 92(9), 2001, pp. 968-974
10. Bielawski, K; Bielawska, A; Wolczynski, S
    Aromatic extended bisamidines: Synthesis, inhibition of topoisomerases, and anticancer cytotoxicity in vitro
    ARCHIV DER PHARMAZIE
    
    K. Bielawski et al., "Aromatic extended bisamidines: Synthesis, inhibition of topoisomerases, and anticancer cytotoxicity in vitro", ARCH PHARM, 334(7), 2001, pp. 235-240
11. Ivanova, LV; Rudolph, P; Shilov, YM; Gieseler, F; Alm, P; Tareeva, IE; Proppe, D
    Correlation between the expression of DNA topoisomerases I and II alpha and clinical parameters in kidney disease
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    L.V. Ivanova et al., "Correlation between the expression of DNA topoisomerases I and II alpha and clinical parameters in kidney disease", AM J KIDNEY, 38(5), 2001, pp. 1026-1037
12. Lucas, I; Germe, T; Chevrier-Miller, M; Hyrien, O
    Topoisomerase II can unlink replicating DNA by precatenane removal
    EMBO JOURNAL
    
    I. Lucas et al., "Topoisomerase II can unlink replicating DNA by precatenane removal", EMBO J, 20(22), 2001, pp. 6509-6519
13. Gopal, YNV; Kondapi, AK
    Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium
    JOURNAL OF BIOSCIENCES
    
    Y.N.V. Gopal e A.K. Kondapi, "Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium", J BIOSCI, 26(2), 2001, pp. 271-276
14. Mokdsi, G; Harding, MM
    Inhibition of human topoisomerase II by the antitumor metallocenes
    JOURNAL OF INORGANIC BIOCHEMISTRY
    
    G. Mokdsi e M.M. Harding, "Inhibition of human topoisomerase II by the antitumor metallocenes", J INORG BIO, 83(2-3), 2001, pp. 205-209
15. Uggla, B; Mollgard, L; Stahl, E; Mossberg, LL; Karlsson, MG; Paul, C; Tidefelt, U
    Expression of topoisomerase II alpha in the G0/G1 cell cycle phase of fresh leukemic cells
    LEUKEMIA RESEARCH
    
    B. Uggla et al., "Expression of topoisomerase II alpha in the G0/G1 cell cycle phase of fresh leukemic cells", LEUK RES, 25(11), 2001, pp. 961-966
16. Slesarev, AI; Belova, GI; Lake, JA; Kozyavkin, SA
    Topoisomerase V from Methanopyrus kandleri
    HYPERTHERMOPHILIC ENZYMES, PT C
    
    A.I. Slesarev et al., "Topoisomerase V from Methanopyrus kandleri", METH ENZYM, 334, 2001, pp. 179-192
17. Huang, CH; Treat, J
    New advances in lung cancer chemotherapy: Topotecan and the role of topoisomerase I inhibitors
    ONCOLOGY
    
    C.H. Huang e J. Treat, "New advances in lung cancer chemotherapy: Topotecan and the role of topoisomerase I inhibitors", ONCOL-BASEL, 61, 2001, pp. 14-24
18. Morris, RE; Aird, RE; Murdoch, PD; Chen, HM; Cummings, J; Hughes, ND; Parsons, S; Parkin, A; Boyd, G; Jodrell, DI; Sadler, PJ
    Inhibition of cancer cell growth by ruthenium(II) arene complexes
    JOURNAL OF MEDICINAL CHEMISTRY
    
    R.E. Morris et al., "Inhibition of cancer cell growth by ruthenium(II) arene complexes", J MED CHEM, 44(22), 2001, pp. 3616-3621
19. Lisby, M; Olesen, JR; Skouboe, C; Krogh, BO; Straub, T; Boege, F; Velmurugan, S; Martensen, PM; Andersen, AH; Jayaram, M; Westergaard, O; Knudsen, BR
    Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M. Lisby et al., "Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation", J BIOL CHEM, 276(23), 2001, pp. 20220-20227
20. Aguilar-Mahecha, A; Hales, BF; Robaire, B
    Expression of stress response genes in germ cells during spermatogenesis
    BIOLOGY OF REPRODUCTION
    
    A. Aguilar-Mahecha et al., "Expression of stress response genes in germ cells during spermatogenesis", BIOL REPROD, 65(1), 2001, pp. 119-127
21. Berger, SJ; Gupta, S; Belfi, CA; Gosky, DM; Mukhtar, H
    Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    S.J. Berger et al., "Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells", BIOC BIOP R, 288(1), 2001, pp. 101-105
22. Feister, HA; Onyia, JE; Miles, RR; Yang, X; Galvin, R; Hock, JM; Bidwell, JP
    The expression of the nuclear matrix proteins NuMA, topoisomerase II-alpha, and -beta in bone and osseous cell culture: Regulation by parathyroid hormone
    BONE
    
    H.A. Feister et al., "The expression of the nuclear matrix proteins NuMA, topoisomerase II-alpha, and -beta in bone and osseous cell culture: Regulation by parathyroid hormone", BONE, 26(3), 2000, pp. 227-234
23. Russell, LB; Hunsicker, PR; Hack, AM; Ashley, T
    Effect of the topoisomerase-II inhibitor etoposide on meiotic recombination in male mice
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    
    L.B. Russell et al., "Effect of the topoisomerase-II inhibitor etoposide on meiotic recombination in male mice", MUT RES-GTE, 464(2), 2000, pp. 201-212
24. Hofland, K; Petersen, BO; Falck, J; Helin, K; Jensen, PB; Sehested, M
    Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex
    CLINICAL CANCER RESEARCH
    
    K. Hofland et al., "Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex", CLIN CANC R, 6(4), 2000, pp. 1488-1497
25. Rangarajan, M; Kim, JS; Jin, S; Sim, SP; Liu, A; Pilch, DS; Liu, LF; LaVoie, EJ
    2 ''-substituted 5-phenylterbenzimidazoles as topoisomerase I poisons
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    M. Rangarajan et al., "2 ''-substituted 5-phenylterbenzimidazoles as topoisomerase I poisons", BIO MED CH, 8(6), 2000, pp. 1371-1382
26. Rangarajan, M; Kim, JS; Sim, SP; Liu, A; Liu, LF; LaVoie, EJ
    Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    M. Rangarajan et al., "Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles", BIO MED CH, 8(11), 2000, pp. 2591-2600
27. Rappa, G; Shyam, K; Lorico, A; Fodstad, O; Sartorelli, AC
    Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16)
    ONCOLOGY RESEARCH
    
    G. Rappa et al., "Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16)", ONCOL RES, 12(3), 2000, pp. 113-119
28. Neale, MH; Charlton, PA; Cree, IA
    Ex vivo activity of XR5000 against solid tumors
    ANTI-CANCER DRUGS
    
    M.H. Neale et al., "Ex vivo activity of XR5000 against solid tumors", ANTI-CANC D, 11(6), 2000, pp. 471-478
29. Franchitto, A; Pichierri, P; Mosesso, P; Palitti, F
    Catalytic inhibition of topoisomerase II in Werner's syndrome cell lines enhances chromosomal damage induced by X-rays in the G2 phase of the cell cycle
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    
    A. Franchitto et al., "Catalytic inhibition of topoisomerase II in Werner's syndrome cell lines enhances chromosomal damage induced by X-rays in the G2 phase of the cell cycle", INT J RAD B, 76(7), 2000, pp. 913-922
30. Gieseler, F; Clark, M; Stiebeling, K; Puschmann, M; Valsamas, S
    Induction of apoptosis by idarubicin: how important is the plasma peak?
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    
    F. Gieseler et al., "Induction of apoptosis by idarubicin: how important is the plasma peak?", INT J CL PH, 38(4), 2000, pp. 217-221
31. Hirata, S; Katoh, O; Oguri, T; Watanabe, H; Yajin, K
    Expression of drug resistance-related genes in head and neck squamous cellcarcinoma and normal mucosa
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    S. Hirata et al., "Expression of drug resistance-related genes in head and neck squamous cellcarcinoma and normal mucosa", JPN J CANC, 91(1), 2000, pp. 84-90
32. 
    TAS-103 - Oncolytic topoisomerase inhibitor
    DRUGS OF THE FUTURE
    
    DRUG FUTURE, 25(5), 2000, pp. 540-541
33. Etievant, C; Kruczynski, A; Barret, JM; Perrin, D; van Hille, B; Guminski, Y; Hill, BT
    F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    C. Etievant et al., "F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103", CANC CHEMOT, 46(2), 2000, pp. 101-113
34. Minderman, H; Wrzosek, C; Cao, SS; Utsugi, T; Kobunai, T; Yamada, Y; Rustum, YM
    Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    H. Minderman et al., "Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells", CANC CHEMOT, 45(1), 2000, pp. 78-84
35. Miettinen, HE; Jarvinen, TAH; Kellner, U; Kauraniemi, P; Parwaresch, R; Rantala, I; Kalimo, H; Paljarvi, L; Isola, J; Haapasalo, H
    High topoisomerase II alpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    H.E. Miettinen et al., "High topoisomerase II alpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas", NEUROP AP N, 26(6), 2000, pp. 504-512
36. Darcy, IK; Sumners, DW
    Rational tangle distances on knots and links
    MATHEMATICAL PROCEEDINGS OF THE CAMBRIDGE PHILOSOPHICAL SOCIETY
    
    I.K. Darcy e D.W. Sumners, "Rational tangle distances on knots and links", MATH PROC C, 128, 2000, pp. 497-510
37. Ji, SC
    Free energy and information contents of Conformons in proteins and DNA
    BIOSYSTEMS
    
    S.C. Ji, "Free energy and information contents of Conformons in proteins and DNA", BIOSYSTEMS, 54(3), 2000, pp. 107-130
38. Rappa, G; Murren, JR; Johnson, LM; Lorico, A; Sartorelli, AC
    Novobiocin-induced VP-16 accumulation and MRP expression in human leukemiaand ovarian carcinoma cells
    ANTI-CANCER DRUG DESIGN
    
    G. Rappa et al., "Novobiocin-induced VP-16 accumulation and MRP expression in human leukemiaand ovarian carcinoma cells", ANTI-CAN DR, 15(2), 2000, pp. 127-134
39. Mizushina, Y; Iida, A; Ohta, K; Sugawara, F; Sakaguchi, K
    Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase
    BIOCHEMICAL JOURNAL
    
    Y. Mizushina et al., "Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase", BIOCHEM J, 350, 2000, pp. 757-763
40. Li, Q; Mitscher, LA; Shen, LL
    The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors
    MEDICINAL RESEARCH REVIEWS
    
    Q. Li et al., "The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors", MED RES REV, 20(4), 2000, pp. 231-293
41. Shpitz, B; Bomstein, Y; Zehavi, T; Bernheim, J; Liverant, S; Kaufman, Z; Buklan, G; Klein, E
    Topoisomerase II alpha expression in ductal carcinoma in situ of the breast: A preliminary study
    HUMAN PATHOLOGY
    
    B. Shpitz et al., "Topoisomerase II alpha expression in ductal carcinoma in situ of the breast: A preliminary study", HUMAN PATH, 31(10), 2000, pp. 1249-1254
42. Mirski, SEL; Voskoglou-Nomikos, T; Young, LC; Deeley, RG; Campling, BG; Gerlach, JH; Cole, SPC
    Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAsin lung tumor cells and normal and malignant lung tissue
    LABORATORY INVESTIGATION
    
    S.E.L. Mirski et al., "Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAsin lung tumor cells and normal and malignant lung tissue", LAB INV, 80(6), 2000, pp. 787-795
43. Satherley, K; de Souza, L; Neale, MH; Alexander, RA; Myatt, N; Foss, AJE; Hungerford, JL; Hickson, ID; Cree, IA
    Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma
    JOURNAL OF PATHOLOGY
    
    K. Satherley et al., "Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma", J PATHOLOGY, 192(2), 2000, pp. 174-181
44. Goswami, PC; Sheren, J; Albee, LD; Parsian, A; Sim, JE; Ridnour, LA; Higashikubo, R; Gius, D; Hunt, CR; Spitz, DR
    Cell cycle-coupled variation in topoisomerase II alpha mRNA is regulated by the 3 '-untranslated region - Possible role of redox-sensitive protein binding in mRNA accumulation
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    P.C. Goswami et al., "Cell cycle-coupled variation in topoisomerase II alpha mRNA is regulated by the 3 '-untranslated region - Possible role of redox-sensitive protein binding in mRNA accumulation", J BIOL CHEM, 275(49), 2000, pp. 38384-38392
45. Edwards, TK; Saleem, A; Shaman, JA; Dennis, T; Gerigk, C; Oliveros, E; Gartenberg, MR; Rubin, EH
    Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    T.K. Edwards et al., "Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I", J BIOL CHEM, 275(46), 2000, pp. 36181-36188
46. Declais, AC; Marsault, J; Confalonieri, F; de La Tour, CB; Duguet, M
    Reverse gyrase, the two domains intimately cooperate to promote positive supercoiling
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A.C. Declais et al., "Reverse gyrase, the two domains intimately cooperate to promote positive supercoiling", J BIOL CHEM, 275(26), 2000, pp. 19498-19504
47. Bhaduri, T; Basak, S; Sikder, D; Nagaraja, V
    Inhibition of Mycobacterium smegmatis topoisomerase I by specific oligonucleotides
    FEBS LETTERS
    
    T. Bhaduri et al., "Inhibition of Mycobacterium smegmatis topoisomerase I by specific oligonucleotides", FEBS LETTER, 486(2), 2000, pp. 126-130
48. Satterwhite, DJ; White, RL; Matsunami, N; Neufeld, KL
    Inhibition of topoisomerase II alpha expression by transforming growth factor-beta 1 is abrogated by the papillomavirus E7 protein
    CANCER RESEARCH
    
    D.J. Satterwhite et al., "Inhibition of topoisomerase II alpha expression by transforming growth factor-beta 1 is abrogated by the papillomavirus E7 protein", CANCER RES, 60(24), 2000, pp. 6989-6994
49. Hopfner, R; Mousli, M; Jeltsch, JM; Voulgaris, A; Lutz, Y; Marin, C; Bellocq, JP; Oudet, P; Bronner, C
    ICBP90, a novel human CCAAT binding protein, involved in the regulation oftopoisomerase II alpha expression
    CANCER RESEARCH
    
    R. Hopfner et al., "ICBP90, a novel human CCAAT binding protein, involved in the regulation oftopoisomerase II alpha expression", CANCER RES, 60(1), 2000, pp. 121-128
50. Valkov, NI; Gump, JL; Engel, R; Sullivan, DM
    Cell density-dependent VP-16 sensitivity of leukaemic cells is accompaniedby the translocation of topoisomerase II alpha from the nucleus to the cytoplasm
    BRITISH JOURNAL OF HAEMATOLOGY
    
    N.I. Valkov et al., "Cell density-dependent VP-16 sensitivity of leukaemic cells is accompaniedby the translocation of topoisomerase II alpha from the nucleus to the cytoplasm", BR J HAEM, 108(2), 2000, pp. 331-345
51. Pommier, Y; Pourquier, P; Urasaki, Y; Wu, JX; Laco, GS
    Topoisomerase I inhibitors: selectivity and cellular resistance
    DRUG RESISTANCE UPDATES
    
    Y. Pommier et al., "Topoisomerase I inhibitors: selectivity and cellular resistance", DRUG RESIST, 2(5), 1999, pp. 307-318
52. Spaltmann, F; Lohrmann, E; Ziegelbauer, K
    A target-specific cellular assay for screening of topoisomerase I inhibitors
    JOURNAL OF BIOMOLECULAR SCREENING
    
    F. Spaltmann et al., "A target-specific cellular assay for screening of topoisomerase I inhibitors", J BIOMOL SC, 4(2), 1999, pp. 93-100
53. Wu, L; Karow, JK; Hickson, ID
    Genetic recombination: Helicases and topoisomerases link up
    CURRENT BIOLOGY
    
    L. Wu et al., "Genetic recombination: Helicases and topoisomerases link up", CURR BIOL, 9(14), 1999, pp. R518-R520
54. van Hille, B; Perrin, D; Hill, BT
    Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase II alpha and II beta isoforms
    ANTI-CANCER DRUGS
    
    B. van Hille et al., "Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase II alpha and II beta isoforms", ANTI-CANC D, 10(6), 1999, pp. 551-560
55. Pastor, N; Pinero, J; Ortiz, T; Mateos, JC; De Miguel, M; Cortes, F
    Topoisomerase activities and levels in irradiated Chinese hamster AA8 cells and in its radiosensitive mutant EM9
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    
    N. Pastor et al., "Topoisomerase activities and levels in irradiated Chinese hamster AA8 cells and in its radiosensitive mutant EM9", INT J RAD B, 75(8), 1999, pp. 1035-1042
56. Ohyama, T; Li, Y; Utsugi, T; Irie, S; Yamada, Y; Sato, T
    A dual topoisomerase inhibitor, TAS-103, induces apoptosis in human cancercells
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    T. Ohyama et al., "A dual topoisomerase inhibitor, TAS-103, induces apoptosis in human cancercells", JPN J CANC, 90(6), 1999, pp. 691-698
57. Turnbull, RM; Meczes, EL; Rogers, MP; Lock, RB; Sullivan, DM; Finlay, GJ; Baguley, BC; Austin, CA
    Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases II alpha and beta
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    R.M. Turnbull et al., "Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases II alpha and beta", CANC CHEMOT, 44(4), 1999, pp. 275-282
58. Ng, SW; Liu, Y; Hasselblatt, KT; Mok, SC; Berkowitz, RS
    A new human topoisomerase III that interacts with SGS1 protein
    NUCLEIC ACIDS RESEARCH
    
    S.W. Ng et al., "A new human topoisomerase III that interacts with SGS1 protein", NUCL ACID R, 27(4), 1999, pp. 993-1000
59. Broccoli, S; Marquis, JF; Papadopoulou, B; Olivier, M; Drolet, M
    Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase
    NUCLEIC ACIDS RESEARCH
    
    S. Broccoli et al., "Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase", NUCL ACID R, 27(13), 1999, pp. 2745-2752
60. Nagao, T; Yoshimura, S; Saito, Y; Imai, K
    Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administration
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    
    T. Nagao et al., "Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administration", TER CAR MUT, 19(3), 1999, pp. 233-241
61. Kim, R; Ohi, Y; Inoue, H; Toge, T
    Expression and relationship between topoisomerase I and II a genes in tumor and normal tissues in esophageal, gastric and colon cancers
    ANTICANCER RESEARCH
    
    R. Kim et al., "Expression and relationship between topoisomerase I and II a genes in tumor and normal tissues in esophageal, gastric and colon cancers", ANTICANC R, 19(6B), 1999, pp. 5393-5398
62. Ramakrishnan, T; Chandrasekhar, P
    The control of tuberculosis: a continuous game of snakes and ladders
    JOURNAL OF BIOSCIENCES
    
    T. Ramakrishnan e P. Chandrasekhar, "The control of tuberculosis: a continuous game of snakes and ladders", J BIOSCI, 24(2), 1999, pp. 143-152
63. Breault, GA; Hunter, CA; Mayers, PC
    Supramolecular topology
    TETRAHEDRON
    
    G.A. Breault et al., "Supramolecular topology", TETRAHEDRON, 55(17), 1999, pp. 5265-5293
64. Mongelli, E; Romano, A; Desmarchelier, C; Coussio, J; Ciccia, G
    Cytotoxic 4-nerolidylcatechol from Pothomorphe peltata inhibits topoisomerase I activity
    PLANTA MEDICA
    
    E. Mongelli et al., "Cytotoxic 4-nerolidylcatechol from Pothomorphe peltata inhibits topoisomerase I activity", PLANTA MED, 65(4), 1999, pp. 376-378
65. Bhat, UG; Raychaudhuri, P; Beck, WT
    Functional interaction between human topoisomerase II alpha and retinoblastoma protein
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    U.G. Bhat et al., "Functional interaction between human topoisomerase II alpha and retinoblastoma protein", P NAS US, 96(14), 1999, pp. 7859-7864
66. Yakubovskaya, EA; Gabibov, AG
    Topoisomerases: Mechanisms of DNA topological alterations
    MOLECULAR BIOLOGY
    
    E.A. Yakubovskaya e A.G. Gabibov, "Topoisomerases: Mechanisms of DNA topological alterations", MOL BIOL, 33(3), 1999, pp. 318-332
67. Wang, X; Watt, PM; Borts, RH; Louis, EJ; Hickson, ID
    The topoisomerase II-associated protein, Pat1p, is required for maintenance of rDNA locus stability in Saccharomyces cerevisiae
    MOLECULAR AND GENERAL GENETICS
    
    X. Wang et al., "The topoisomerase II-associated protein, Pat1p, is required for maintenance of rDNA locus stability in Saccharomyces cerevisiae", MOL G GENET, 261(4-5), 1999, pp. 831-840
68. Lopez-Garcia, P
    DNA supercoiling and temperature adaptation: A clue to early diversification of life?
    JOURNAL OF MOLECULAR EVOLUTION
    
    P. Lopez-Garcia, "DNA supercoiling and temperature adaptation: A clue to early diversification of life?", J MOL EVOL, 49(4), 1999, pp. 439-452
69. Redinbo, MR; Stewart, L; Champoux, JJ; Hol, WGJ
    Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures
    JOURNAL OF MOLECULAR BIOLOGY
    
    M.R. Redinbo et al., "Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures", J MOL BIOL, 292(3), 1999, pp. 685-696
70. Bouille, P; Subra, F; Mouscadet, JF; Auclair, C
    Antisense-mediated repression of RNA topoisomerase II expression leads to an impairment of HIV-1 replicative cycle
    JOURNAL OF MOLECULAR BIOLOGY
    
    P. Bouille et al., "Antisense-mediated repression of RNA topoisomerase II expression leads to an impairment of HIV-1 replicative cycle", J MOL BIOL, 285(3), 1999, pp. 945-954
71. Ma, ZK; Chu, DTW; Cooper, CS; Li, Q; Fung, AKL; Wang, SY; Shen, LL; Flamm, RK; Nilius, AM; Alder, JD; Meulbroek, JA; Or, YS
    Synthesis and antimicrobial activity of 4H-4-Oxoquinolizine derivatives: Consequences of structural modification at the C-8 position
    JOURNAL OF MEDICINAL CHEMISTRY
    
    Z.K. Ma et al., "Synthesis and antimicrobial activity of 4H-4-Oxoquinolizine derivatives: Consequences of structural modification at the C-8 position", J MED CHEM, 42(20), 1999, pp. 4202-4213
72. Walowsky, C; Fitzhugh, DJ; Castano, IB; Ju, JY; Levin, NA; Christman, MF
    The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    C. Walowsky et al., "The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin", J BIOL CHEM, 274(11), 1999, pp. 7302-7308
73. Del Poeta, M; Toffaletti, DL; Rude, TH; Dykstra, CC; Heitman, J; Perfect, JR
    Topoisomerase I is essential in Cryptococcus neoformans: Role in pathobiology and as an antifungal target
    GENETICS
    
    M. Del Poeta et al., "Topoisomerase I is essential in Cryptococcus neoformans: Role in pathobiology and as an antifungal target", GENETICS, 152(1), 1999, pp. 167-178
74. Asis, SE; Bruno, AM; Martinez, AR; Sevilla, MV; Gaozza, CH; Romano, AM; Coussio, JD; Ciccia, G
    Diarylsemicarbazones: synthesis, antineoplastic activity and topoisomeraseI inhibition assay
    FARMACO
    
    S.E. Asis et al., "Diarylsemicarbazones: synthesis, antineoplastic activity and topoisomeraseI inhibition assay", FARMACO, 54(8), 1999, pp. 517-523
75. Hooper, DC
    Mode of action of fluoroquinolones
    DRUGS
    
    D.C. Hooper, "Mode of action of fluoroquinolones", DRUGS, 58, 1999, pp. 6-10
76. RAMIREZSANTOYO R; LOPEZSWIDERSKI A; AVALOSDIAZ E; HERRERAESPARZA R
    THE EXPRESSION AND LOCALIZATION OF SCL-70 DNA TOPOISOMERASE-I VARY THROUGHOUT THE CELL-CYCLE/
    Revue du rhumatisme
    
    R. Ramirezsantoyo et al., "THE EXPRESSION AND LOCALIZATION OF SCL-70 DNA TOPOISOMERASE-I VARY THROUGHOUT THE CELL-CYCLE/", Revue du rhumatisme, 65(3), 1998, pp. 165-172
77. SUI ZH; ALTOM J; NGUYEN V; FERNANDEZ J; BERNSTEIN JI; HILIARD JJ; BARRETT JF; PODLOGAR BL; OHEMENG KA
    SYNTHESIS AND INHIBITORY ACTIVITY OF NOVEL TRICYCLIC AND TETRACYCLIC QUINOLINES AGAINST TOPOISOMERASES
    Bioorganic & medicinal chemistry
    
    Z.H. Sui et al., "SYNTHESIS AND INHIBITORY ACTIVITY OF NOVEL TRICYCLIC AND TETRACYCLIC QUINOLINES AGAINST TOPOISOMERASES", Bioorganic & medicinal chemistry, 6(6), 1998, pp. 735-742
78. KIM JS; SUN Q; YU C; LIU A; LIU LF; LAVOIE EJ
    QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS ON 5-SUBSTITUTED TERBENZIMIDAZOLES AS TOPOISOMERASE-I POISONS AND ANTITUMOR AGENTS
    Bioorganic & medicinal chemistry
    
    J.S. Kim et al., "QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS ON 5-SUBSTITUTED TERBENZIMIDAZOLES AS TOPOISOMERASE-I POISONS AND ANTITUMOR AGENTS", Bioorganic & medicinal chemistry, 6(2), 1998, pp. 163-172
79. DOLAN ME; FRYDMAN B; THOMPSON CB; DIAMOND AM; GARBIRAS BJ; SAFA AR; BECK WT; MARTON LJ
    EFFECTS OF 1,2-NAPHTHOQUINONES ON HUMAN TUMOR-CELL GROWTH AND LACK OFCROSS-RESISTANCE WITH OTHER ANTICANCER AGENTS
    Anti-cancer drugs
    
    M.E. Dolan et al., "EFFECTS OF 1,2-NAPHTHOQUINONES ON HUMAN TUMOR-CELL GROWTH AND LACK OFCROSS-RESISTANCE WITH OTHER ANTICANCER AGENTS", Anti-cancer drugs, 9(5), 1998, pp. 437-448
80. HAYASHI M; ICHIKAWA Y; ARAI S; ENDOH D; OKUI T
    HIGHER SENSITIVITY IN LEC RAT-CELLS TO A TOPOISOMERASE-II INHIBITOR, ELLIPTICINE
    Journal of veterinary medical science
    
    M. Hayashi et al., "HIGHER SENSITIVITY IN LEC RAT-CELLS TO A TOPOISOMERASE-II INHIBITOR, ELLIPTICINE", Journal of veterinary medical science, 60(8), 1998, pp. 969-971
81. FERGUSON LR; TURNER PM; HART DW; TINDALL KR
    AMSACRINE-INDUCED MUTATIONS IN AS52 CELLS
    Environmental and molecular mutagenesis
    
    L.R. Ferguson et al., "AMSACRINE-INDUCED MUTATIONS IN AS52 CELLS", Environmental and molecular mutagenesis, 32(1), 1998, pp. 47-55
82. MASUDA N; MATSUI K; NEGORO S; TAKIFUJI N; TAKEDA K; YANA T; KOBAYASHI M; HIRASHIMA T; KUSUNOKI Y; USHIJIMA S; KAWASE I; TADA T; SAWAGUCHI H; FUKUOKA M
    COMBINATION OF IRINOTECAN AND ETOPOSIDE FOR TREATMENT OF REFRACTORY OR RELAPSED SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    N. Masuda et al., "COMBINATION OF IRINOTECAN AND ETOPOSIDE FOR TREATMENT OF REFRACTORY OR RELAPSED SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 16(10), 1998, pp. 3329-3334
83. ROBERT J; LARSEN AK
    DRUG-RESISTANCE TO TOPOISOMERASE-II INHIBITORS
    Biochimie
    
    J. Robert e A.K. Larsen, "DRUG-RESISTANCE TO TOPOISOMERASE-II INHIBITORS", Biochimie, 80(3), 1998, pp. 247-254
84. Lee, HK; Lee, DS; Lim, J; Kim, JS; Im, KS; Jung, JH
    Topoisomerase I inhibitors from the Streptomyces sp. strain KM86-9B isolated from a marine sponge
    ARCHIVES OF PHARMACAL RESEARCH
    
    H.K. Lee et al., "Topoisomerase I inhibitors from the Streptomyces sp. strain KM86-9B isolated from a marine sponge", ARCH PH RES, 21(6), 1998, pp. 729-733
85. Miller, MC; Stineman, CN; Vance, JR; West, DX; Hall, IH
    The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-N-4-substituted thiosemicarbazones
    ANTICANCER RESEARCH
    
    M.C. Miller et al., "The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-N-4-substituted thiosemicarbazones", ANTICANC R, 18(6A), 1998, pp. 4131-4139
86. TSEDINH YC
    BACTERIAL AND ARCHEAL TYPE-I TOPOISOMERASES
    Biochimica et biophysica acta, N. Gene structure and expression
    
    Y.C. Tsedinh, "BACTERIAL AND ARCHEAL TYPE-I TOPOISOMERASES", Biochimica et biophysica acta, N. Gene structure and expression, 1400(1-3), 1998, pp. 19-27
87. BAGULEY BC; FERGUSON LR
    MUTAGENIC PROPERTIES OF TOPOISOMERASE-TARGETED DRUGS
    Biochimica et biophysica acta, N. Gene structure and expression
    
    B.C. Baguley e L.R. Ferguson, "MUTAGENIC PROPERTIES OF TOPOISOMERASE-TARGETED DRUGS", Biochimica et biophysica acta, N. Gene structure and expression, 1400(1-3), 1998, pp. 213-222
88. HAMMONDS TR; MAXWELL A; JENKINS JR
    USE OF A RAPID THROUGHPUT IN-VIVO SCREEN TO INVESTIGATE INHIBITORS OFEUKARYOTIC TOPOISOMERASE-II ENZYMES
    Antimicrobial agents and chemotherapy
    
    T.R. Hammonds et al., "USE OF A RAPID THROUGHPUT IN-VIVO SCREEN TO INVESTIGATE INHIBITORS OFEUKARYOTIC TOPOISOMERASE-II ENZYMES", Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 889-894
89. NASH HA
    PROTEIN-STRUCTURE - TOPOLOGICAL NUTS AND BOLTS
    Science
    
    H.A. Nash, "PROTEIN-STRUCTURE - TOPOLOGICAL NUTS AND BOLTS", Science, 279(5356), 1998, pp. 1490-1491
90. MOREIRA D; LOPEZGARCIA P
    SYMBIOSIS BETWEEN METHANOGENIC ARCHAEA AND DELTA-PROTEOBACTERIA AS THE ORIGIN OF EUKARYOTES - THE SYNTROPHIC HYPOTHESIS
    Journal of molecular evolution
    
    D. Moreira e P. Lopezgarcia, "SYMBIOSIS BETWEEN METHANOGENIC ARCHAEA AND DELTA-PROTEOBACTERIA AS THE ORIGIN OF EUKARYOTES - THE SYNTROPHIC HYPOTHESIS", Journal of molecular evolution, 47(5), 1998, pp. 517-530
91. FANG M; WU HY
    SUPPRESSION OF LEU-500 MUTATION IN TOPA-TYPHIMURIUM STRAINS - THE PROMOTER RELAY AT WORK( SALMONELLA)
    The Journal of biological chemistry
    
    M. Fang e H.Y. Wu, "SUPPRESSION OF LEU-500 MUTATION IN TOPA-TYPHIMURIUM STRAINS - THE PROMOTER RELAY AT WORK( SALMONELLA)", The Journal of biological chemistry, 273(45), 1998, pp. 29929-29934
92. SABOURIN M; BYL JAW; HANNAH SE; NITISS JL; OSHEROFF N
    A MUTANT YEAST TOPOISOMERASE-II (TOP2G437S) WITH DIFFERENTIAL SENSITIVITY TO ANTICANCER DRUGS IN THE PRESENCE AND ABSENCE OF ATP
    The Journal of biological chemistry
    
    M. Sabourin et al., "A MUTANT YEAST TOPOISOMERASE-II (TOP2G437S) WITH DIFFERENTIAL SENSITIVITY TO ANTICANCER DRUGS IN THE PRESENCE AND ABSENCE OF ATP", The Journal of biological chemistry, 273(44), 1998, pp. 29086-29092
93. FANG M; WU HY
    A PROMOTER RELAY MECHANISM FOR SEQUENTIAL GENE ACTIVATION
    Journal of bacteriology
    
    M. Fang e H.Y. Wu, "A PROMOTER RELAY MECHANISM FOR SEQUENTIAL GENE ACTIVATION", Journal of bacteriology, 180(3), 1998, pp. 626-633
94. BOJANOWSKI K; INGBER DE
    IONIC CONTROL OF CHROMOSOME ARCHITECTURE IN LIVING AND PERMEABILIZED CELLS
    Experimental cell research
    
    K. Bojanowski e D.E. Ingber, "IONIC CONTROL OF CHROMOSOME ARCHITECTURE IN LIVING AND PERMEABILIZED CELLS", Experimental cell research, 244(1), 1998, pp. 286-294
95. Grigolo, B; Mazzetti, I; Borzi, RM; Hickson, ID; Fabbri, M; Fasano, L; Meliconi, R; Facchini, A
    Mapping of topoisomerase II alpha epitopes recognized by autoantibodies inidiopathic pulmonary fibrosis
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    B. Grigolo et al., "Mapping of topoisomerase II alpha epitopes recognized by autoantibodies inidiopathic pulmonary fibrosis", CLIN EXP IM, 114(3), 1998, pp. 339-346
96. JARVINEN TAH; HOLLI K; KUUKASJARVI T; ISOLA JJ
    PREDICTIVE VALUE OF TOPOISOMERASE II-ALPHA AND OTHER PROGNOSTIC FACTORS FOR EPIRUBICIN CHEMOTHERAPY IN ADVANCED BREAST-CANCER
    British Journal of Cancer
    
    T.A.H. Jarvinen et al., "PREDICTIVE VALUE OF TOPOISOMERASE II-ALPHA AND OTHER PROGNOSTIC FACTORS FOR EPIRUBICIN CHEMOTHERAPY IN ADVANCED BREAST-CANCER", British Journal of Cancer, 77(12), 1998, pp. 2267-2273
97. PERRIN D; VANHILLE B; HILL BT
    DIFFERENTIAL SENSITIVITIES OF RECOMBINANT HUMAN TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA TO VARIOUS CLASSES OF TOPOISOMERASE-II INTERACTING AGENTS
    Biochemical pharmacology
    
    D. Perrin et al., "DIFFERENTIAL SENSITIVITIES OF RECOMBINANT HUMAN TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA TO VARIOUS CLASSES OF TOPOISOMERASE-II INTERACTING AGENTS", Biochemical pharmacology, 56(4), 1998, pp. 503-507
98. MEDDERS WM; WOOLEY RE; GIBBS PS; SHOTTS EB; BROWN J
    MUTATION-RATE OF AVIAN INTESTINAL COLIFORM BACTERIA WHEN PRESSURED WITH FLUOROQUINOLONES
    Avian diseases
    
    W.M. Medders et al., "MUTATION-RATE OF AVIAN INTESTINAL COLIFORM BACTERIA WHEN PRESSURED WITH FLUOROQUINOLONES", Avian diseases, 42(1), 1998, pp. 146-153
99. LARSEN AK; GOBERT C; GILBERT C; MARKOVITS J; BOJANOWSKI K; SKLADANOWSKI A
    DNA TOPOISOMERASES AS REPAIR ENZYMES - MECHANISM(S) OF ACTION AND REGULATION BY P53
    Acta Biochimica Polonica
    
    A.K. Larsen et al., "DNA TOPOISOMERASES AS REPAIR ENZYMES - MECHANISM(S) OF ACTION AND REGULATION BY P53", Acta Biochimica Polonica, 45(2), 1998, pp. 535-544
100. JIANG WD; GERHOLD D; KMIEC EB; HAUSER M; BECKER JM; KOLTIN Y
     THE TOPOISOMERASE-I GENE FROM CANDIDA-ALBICANS
     Microbiology
     
     W.D. Jiang et al., "THE TOPOISOMERASE-I GENE FROM CANDIDA-ALBICANS", Microbiology, 143, 1997, pp. 377-386